Clinical Trial Update: Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of the Fentanyl Transdermal Therapeutic System for cancer-related pain management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fentanyl Transdermal Therapeutic System (TTS) (fentanyl)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Pain, Cancer | Phase 3 | Status: COMPLETED